Tate Stauffer
General Practice · Kingwood, TXNPI 1841047925
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 24.3% of the total.
Across 75 payments — averaging $17.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$312
- Dexcom, Inc.$279
- Lilly USA, LLC$117
- AstraZeneca$82
- Exact Sciences$62
- Amgen$57
- plus $374 from 14 others
What the payments were for
- Food & beverage$1,283100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $312 |
| Dexcom, Inc. | 15 | $279 |
| Lilly USA, LLC | 7 | $117 |
| AstraZeneca | 5 | $82 |
| Exact Sciences | 3 | $62 |
| Amgen | 3 | $57 |
| Inspire Medical Systems, Inc. | 2 | $51 |
| Novo Nordisk | 3 | $51 |
| Astellas Pharma US Inc | 2 | $49 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Viatris Specialty LLC | 1 | $29 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Mylan Specialty L.p. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| GSK | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
| Medtronic | 1 | $14 |
| Echosens North America, Inc. | 1 | $11 |
How this compares
$1,283 in reported general payments places this provider in the 85th percentile of 8,074 general practice providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $618 |
| Pantoprazole Sodium | 17 | $158 |
| Methylprednisolone | 16 | $99 |
| Trazodone Hcl | 13 | $92 |
| Azithromycin | 23 | $63 |
| Ciprofloxacin Hcl | 11 | $63 |
| Montelukast Sodium | 15 | $55 |
| Meloxicam | 16 | $21 |
| Furosemide | 11 | $12 |
| Prednisone | 12 | $11 |
Paid to pharmacies, not to this prescriber.
Other general practice in Kingwood
- Marcus LastimadoFort Bliss$2.3M
- Christina DeanFrisco$1.9M
- Paul ShrodeMissouri City$1.2M
- Alan DouglasSan Antonio$609K
- C Mike MeekAustin$509K
- Young KwonDallas$288K
- Matthew HicksFriendswood$268K
- Kathleen Szelei-StevensHouston$253K
- Hoa TranPearland$156K
- Mitchell KimRichardson$145K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.